CSDDD Omnibus Explained – Practical interpretation (Pharma) Scenerio -2
Where the API supplier sits under CSDDD Key point: The API manufacturer in India/China is a: Direct business partner (Tier 1) Even though geographically outside the EU. Why this is
Another FDA 483 highlighting critical data integrity failures at a sterile manufacturing site in India.
A recent U.S. Food and Drug Administration 483 inspection at Maiva Pharma Pvt. Ltd. (Hosur, Tamil Nadu, India) identified serious deficiencies in the control of original CGMP manuf